These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2542183)

  • 1. Intracellular synthesis of Epstein-Barr virus membrane antigen gp350/220. Inhibitory effect of monensin on its expression.
    Bertoni G; Nguyen QV; Humphreys RE; Sairenji T
    Intervirology; 1989; 30(2):61-73. PubMed ID: 2542183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
    Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE
    J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clones.
    Khyatti M; Patel PC; Menezes J
    Int J Cancer; 1991 Jun; 48(4):591-7. PubMed ID: 1646179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Epstein-Barr virus transcripts in chemically or immunologically-activated cells and in a null cell-line (HLN-STL-C) by in situ hybridization with alkaline phosphatase-linked oligonucleotide probes.
    Hironaka T; Nagasaki M; Morikawa S; Hirai K
    J Virol Methods; 1993 Oct; 44(2-3):141-54. PubMed ID: 8263111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptides to identify antigenic determinants on Epstein-Barr virus gp350/220.
    Bertoni G; Kostyal DA; Reisert PS; Humphreys RE; Sairenji T
    Intervirology; 1990; 31(5):290-4. PubMed ID: 1703134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
    Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of the endogenously expressed Epstein-Barr virus (EBV) envelope glycoprotein gp350 with the viral receptor masks the major EBV-neutralizing epitope and affects gp350-specific ADCC.
    Khyatti M; Ahmad A; Blagdon M; Frade R; Menezes J
    J Leukoc Biol; 1998 Aug; 64(2):192-7. PubMed ID: 9715258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells.
    Boos H; Berger R; Kuklik-Roos C; Iftner T; Mueller-Lantzsch N
    Virology; 1987 Jul; 159(1):161-5. PubMed ID: 3037776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Epstein-Barr virus-induced polypeptides in P3HR-1 cells by protein immunoblot.
    Sculley TB; Sculley DG; Pope JH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1113-22. PubMed ID: 2582083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformation-dependent recognition of baculovirus-expressed Epstein-Barr virus gp350 by a panel of monoclonal antibodies.
    Zhang PF; Marcus-Sekura CJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2171-9. PubMed ID: 7691988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 molecule.
    Tanner JE; Coinçon M; Leblond V; Hu J; Fang JM; Sygusch J; Alfieri C
    J Virol; 2015 May; 89(9):4932-41. PubMed ID: 25694592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110.
    Gong M; Kieff E
    J Virol; 1990 Apr; 64(4):1507-16. PubMed ID: 2157039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of activated serum factor on the induction of Epstein-Barr virus antigens and cell differentiation.
    Roubalová K; Anisimová E; Roubal J
    Arch Virol; 1985; 85(1-2):85-94. PubMed ID: 2990391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation.
    Anisimová E; Prachová K; Roubal J; Vonka V
    Arch Virol; 1984; 81(3-4):223-37. PubMed ID: 6089703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular distribution and life cycle of Epstein-Barr virus in keratinocytes of oral hairy leukoplakia.
    Rabanus JP; Greenspan D; Petersen V; Leser U; Wolf H; Greenspan JS
    Am J Pathol; 1991 Jul; 139(1):185-97. PubMed ID: 1649554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350.
    Mold C; Bradt BM; Nemerow GR; Cooper NR
    J Immunol; 1988 Jun; 140(11):3867-74. PubMed ID: 2836501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity.
    Khyatti M; Patel PC; Stefanescu I; Menezes J
    J Virol; 1991 Feb; 65(2):996-1001. PubMed ID: 1846213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically purified serum factor can induce both Epstein-Barr virus antigen synthesis and cell differentiation.
    Anisimová E; Roubalová K; Bauer G; Roubal J
    Arch Virol; 1987; 94(3-4):309-14. PubMed ID: 3034214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.